Anders Vahlne

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Anders Vahlne, Professor Emeritus i Kliniskl Virologi, Karolinska Institute, före detta chefsöverläkare för det kliniskt virologiska laboratoriet vid Huddinge Universitetssjukhus. Nu medlem av Styrelesen och Exekutiv-kommittén för the Global Virus Network.
Anders Vahlne studerade till läkare vid Göteborgs Universitet, legitimerad läkare sedan 1973 och disputerade där i virologi 1978. 1982-83 tillbringade han som gästforskare vid
Scripps Clinic and Research Foundation i La Jolla, CA, med ett Fogarty Fellowship. Anders Vahlne var medlem av the President’s Advisory Board for the Irish National Virus Reference Laboratory vid University College Dublin från 2010 to 2021. Från 1972 till 1986 forskade Anders Vaahlne främst på herpes simplex virus neuropatogenesen. Därefter har hans forskning koncentrerats kring human retroviruses, särskilt HIV.

Forskningsbeskrivning

Herpes simplex virus neurobiology och pathogenes

HIV pathogenes

Virusdiagnostik

Undervisning

Klinisk virologi för medicinstudenter

Artiklar

Article: NATURE. 2022;611(7935):332-345

A multinational Delphi consensus to end the COVID-19 public health threat.

Lazarus JV; Romero D; Kopka CJ; Karim SA; Abu-Raddad LJ; Almeida G; Baptista-Leite R; Barocas JA; Barreto ML; Bar-Yam Y; Bassat Q; Batista C; Bazilian M; Chiou S-T; Del Rio C; Dore GJ; Gao GF; Gostin LO; Hellard M; Jimenez JL; Kang G; Lee N; Matičič M; McKee M; Nsanzimana S; Oliu-Barton M; Pradelski B; Pyzik O; Rabin K; Raina S; Rashid SF; Rathe M; Saenz R; Singh S; Trock-Hempler M; Villapol S; Yap P; Binagwaho A; Kamarulzaman A; El-Mohandes A; COVID-19 Consensus Statement Panel
Article: ANTIVIRAL RESEARCH. 2019;163:140-148

2018 international meeting of the Global Virus Network.

Brechot C; Bryant J; Endtz H; Garry RF; Griffin DE; Lewin SR; Mercer N; Osterhaus A; Picot V; Vahlne A; Verjans GMGM; Weaver S
Article: INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2018;101:103-112

Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein.

Zhang SM; Liao Y; Neo TL; Lu Y; Liu DX; Vahlne A; Tam JP
Article: ANTIVIRAL RESEARCH. 2017;142:21-29

2016 International meeting of the Global Virus Network.

Akkina R; Ellerbrok H; Hall W; Hasegawa H; Kawaguchi Y; Kleanthous H; McSweegan E; Mercer N; Romanowski V; Sawa H; Vahlne A
Article: PLOS ONE. 2015;10(7):e0134851

Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.

Zhang SM; Jejcic A; Tam JP; Vahlne A
Article: SCIENTIFIC REPORTS. 2014;4:7025

Trimeric HIV Env provides epitope occlusion mediated by hypervariable loops.

Moscoso CG; Xing L; Hui J; Hu J; Kalkhoran MB; Yenigun OM; Sun Y; Paavolainen L; Martin L; Vahlne A; Zambonelli C; Barnett SW; Srivastava IK; Cheng RH
Article: JOURNAL OF PHARMACY AND PHARMACOLOGY. 2014;66(10):1388-1393

Anti-human immunodeficiency virus type 1 agent alpha-hydroxy glycineamide enters the target cells via a mechanism of passive diffusion.

Youssefi M; Vahlne A
Journal article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2014;65(&NA;):50

122 Peptide Inhibitors of HIV

Vahlne A
Article: AIDS. 2013;27(15):2355-2364

HIV-1 Tat protein induces viral internalization through Env-mediated interactions in dose-dependent manner.

Poon S; Moscoso CG; Yenigun OM; Kolatkar PR; Cheng RH; Vahlne A
Journal article: AIDS. 2013;27(15):2345-2354

Putative role of Tat-Env interaction in HIV infection.

Poon S; Moscoso CG; Xing L; Kan E; Sun Y; Kolatkar PR; Vahlne AG; Srivastava IK; Barnett SW; Cheng RH
Article: MOLECULAR THERAPY. 2013;21(9):1796-1805

Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.

Weiland O; Ahlén G; Diepolder H; Jung M-C; Levander S; Fons M; Mathiesen I; Sardesai NY; Vahlne A; Frelin L; Sällberg M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(43):17639-17644

Human serum protein enhances HIV-1 replication and up-regulates the transcription factor AP-1.

Perdomo MF; Hosia W; Jejcic A; Corthals GL; Vahlne A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2012;28(9):1052-1058

HIV inhibition by CD4 and CCR5-derived glycopeptides.

Perdomo MF; Sällberg M; Vahlne A
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2011;108(15):6091-6096

Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding.

Moscoso CG; Sun Y; Poon S; Xing L; Kan E; Martin L; Green D; Lin F; Vahlne AG; Barnett S; Srivastava I; Cheng RH
Journal article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011;56(Supplement 2):74

177 Peptide Linkers Between Natural Antibodies and HIV Target

Perdomo M; Sällberg M; Vahlne A
Article: RETROVIROLOGY. 2010;7:20

GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.

Jejcic A; Höglund S; Vahlne A
Article: JOURNAL OF VIROLOGY. 2009;83(19):10075-10084

Small molecule targets Env for endoplasmic reticulum-associated protein degradation and inhibits human immunodeficiency virus type 1 propagation.

Jejcic A; Daniels R; Goobar-Larsson L; Hebert DN; Vahlne A
Article: RETROVIROLOGY. 2009;6:40

A historical reflection on the discovery of human retroviruses.

Vahlne A
Article: RETROVIROLOGY. 2009;6:34

Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology.

Abdurahman S; Végvári A; Levi M; Höglund S; Högberg M; Tong W; Romero I; Balzarini J; Vahlne A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2008;52(10):3737-3744

Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.

Abdurahman S; Végvári A; Youssefi M; Levi M; Höglund S; Andersson E; Horal P; Svennerholm B; Balzarini J; Vahlne A
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(34):12515-12520

Neutralization of HIV-1 by redirection of natural antibodies.

Perdomo MF; Levi M; Sällberg M; Vahlne A
Article: RETROVIROLOGY. 2007;4:69

Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity.

Abdurahman S; Youssefi M; Höglund S; Vahlne A
Article: RETROVIROLOGY. 2007;4:19

Mutation in the loop C-terminal to the cyclophilin A binding site of HIV-1 capsid protein disrupts proper virus assembly and infectivity.

Abdurahman S; Höglund S; Höglund A; Vahlne A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2005;49(3):1087-1092

Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium.

Hubatsch I; Lazorova L; Vahlne A; Artursson P
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2005;49(1):40-44

Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide.

Andersson E; Horal P; Jejcic A; Höglund S; Balzarini J; Vahlne A; Svennerholm B
Article: JOURNAL OF GENERAL VIROLOGY. 2004;85(Pt 10):2903-2913

Selected amino acid substitutions in the C-terminal region of human immunodeficiency virus type 1 capsid protein affect virus assembly and release.

Abdurahman S; Höglund S; Goobar-Larsson L; Vahlne A
Article: INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2004;36(9):1848-1859

Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).

Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
Article: ANTIVIRAL RESEARCH. 2004;61(2):119-124

No cross-resistance or selection of HIV-1 resistant mutants in vitro to the antiretroviral tripeptide glycyl-prolyl-glycine-amide.

Andersson E; Horal P; Vahlne A; Svennerholm B
Article: VIROLOGY. 2003;314(1):179-189

Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner.

Naghavi MH; Nowak P; Andersson J; Sönnerborg A; Yang H; Tracey KJ; Vahlne A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2002;46(11):3597-3605

Tripeptide interference with human immunodeficiency virus type 1 morphogenesis.

Höglund S; Su J; Reneby SS; Végvári A; Hjertén S; Sintorn I-M; Foster H; Wu Y-P; Nyström I; Vahlne A
Journal article: JOURNAL OF BIOMEDICAL SCIENCE. 2002;9(3):234-245

MCEF, the Newest Member of the AF4 Family of Transcription Factors Involved in Leukemia, Is a Positive Transcription Elongation Factor-b-Associated Protein

Estable MC; Naghavi MH; Kato H; Xiao H; Qin J; Vahlne A; Roeder RG
Article: JOURNAL OF BIOMEDICAL SCIENCE. 2002;9(3):234-245

MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein.

Estable MC; Naghavi MH; Kato H; Xiao H; Qin J; Vahlne A; Roeder RG
Article: MOLECULAR THERAPY. 2001;3(4):531-535

Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1.

Maijgren-Steffensson C; Sönnerborg A; Vahlne A; Britton S; Larsson S; Ahrlund-Richter L
Article: JOURNAL OF GENERAL VIROLOGY. 2001;82(Pt 3):547-559

Upstream stimulating factor affects human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in a cell-specific manner, independently of the HIV-1 subtype and the core-negative regulatory element.

Naghavi MH; Estable MC; Schwartz S; Roeder RG; Vahlne A
Article: JOURNAL OF HUMAN VIROLOGY. 2001;4(1):8-15

The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.

Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
Article: JOURNAL OF HUMAN VIROLOGY. 2001;4(1):1-7

The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.

Su J; Andersson E; Horal P; Naghavi MH; Palm A; Wu YP; Eriksson K; Jansson M; Wigzell H; Svennerholm B; Vahlne A
Article: TRANSPLANTATION. 2000;69(8):1733-1736

Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays.

Yun Z; Lewensohn-Fuchs I; Ljungman P; Vahlne A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2000;16(1):37-48

Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells.

Su J; Palm A; Wu Y; Sandin S; Höglund S; Vahlne A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1999;15(14):1293-1303

Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1.

Naghavi MH; Schwartz S; Sönnerborg A; Vahlne A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1999;15(7):609-617

No association of HIV type 1 long terminal repeat sequence pattern with long-term nonprogression and in vivo viral replication levels in European subjects.

Visco-Comandini U; Yun Z; Vahlne A; Sönnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1999;15(5):485-488

DNA sequence of the long terminal repeat of human immunodeficiency virus type 1 subtype A through G.

Naghavi MH; Salminen MO; Sönnerborg A; Vahlne A
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 1998;77(6):591-593

Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia.

Eneroth E; Remberger M; Vahlne A; Ringden O
Article: JOURNAL OF HUMAN VIROLOGY. 1998;1(5):320-327

HIV-1 nef mutations and clinical long-term nonprogression. A molecular epidemiology study.

Visco-Comandini U; Yun Z; Paganelli R; Orlandi P; Salotti A; Johansson B; Vahlne A; Sönnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1998;14(3):241-248

Nonsynonymous mutations within the human immunodeficiency virus type 1 p17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules.

Birk M; Vahlne A; Sönnerborg A; Sällberg M
Article: JOURNAL OF VIROLOGICAL METHODS. 1997;69(1-2):171-180

Quantification of HIV-1 proviral DNA from peripheral blood mononuclear cells using a high throughput four-competitor competitive PCR.

Comandini UV; Sönnerborg A; Vahlne A; Yun Z
Article: CLINICAL AND VACCINE IMMUNOLOGY. 1997;4(5):627-629

Differences in humoral responses to the p24 antigen between Ethiopian and Swedish human immunodeficiency virus type 1-infected patients may suggest influences from a T-helper 2-like phenotype.

Kebede T; Britton S; Fehniger T; Vahlne A; Sällberg M
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1996;12(18):1699-1702

Identification of cross-reactive antigenic target regions for HIV type 1-specific antibody-dependent cellular cytotoxicity.

Broliden K; Von Gegerfelt A; Persson C; Horal P; Svennerholm B; Wahren B; Björling E; Vahlne A
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 1996;59(1):204-212

mtDNA variation indicates Mongolia may have been the source for the founding population for the New World.

Merriwether DA; Hall WW; Vahlne A; Ferrell RE
Article: VIROLOGY. 1996;219(1):161-169

A novel ribozyme target site located in the HIV-1 nef open reading frame.

Larsson S; Hotchkiss G; Su J; Kebede T; Andäng M; Nyholm T; Johansson B; Sönnerborg A; Vahlne A; Britton S; Ahrlund-Richter L
Article: JOURNAL OF NEUROLOGY. 1996;243(3):214-224

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

Lycke J; Svennerholm B; Hjelmquist E; Frisén L; Badr G; Andersson M; Vahlne A; Andersen O
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 1996;11(1):10-19

Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.

Palker TJ; Singer KH; Vahlne A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1995;11(5):637-645

Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in south Vietnam.

Fukushima Y; Takahashi H; Hall WW; Nakasone T; Nakata S; Song P; Dinh Duc D; Hien B; Nguyen XQ; Ngoc Trinh T
Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1994;91(26):12559-12563

Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

Furuta Y; Eriksson K; Svennerholm B; Fredman P; Horal P; Jeansson S; Vahlne A; Holmgren J; Czerkinsky C
Journal article: AIDS. 1994;8(7):971-976

Prevalence of HIV-1 infection in rural, semi-urban and urban villages in southwest Tanzania: estimates from a blood-donor study.

Söderberg S; Temihango W; Kadete C; Ekstedt B; Masawe A; Vahlne A; Horal P
Journal article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 1990;9(10):751-757

Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system.

Bergström T; Alestig K; Svennerholm B; Horal P; Sköldenberg B; Vahlne A
Journal article: ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY. 1988;97(5 Pt 1):554-558

Invasion of cranial nerves and brain stem by herpes simplex virus inoculated into the mouse tongue.

Thomander L; Aldskogius H; Vahlne A; Kristensson K; Thomas E
Journal article: JOURNAL OF GENERAL VIROLOGY. 1986;67 ( Pt 9):2023-2028

Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine].

Kristensson K; Lycke E; Röyttä M; Svennerholm B; Vahlne A
Journal article: JOURNAL OF GENERAL VIROLOGY. 1984;65 ( Pt 1):55-64

Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture.

Lycke E; Kristensson K; Svennerholm B; Vahlne A; Ziegler R
Journal article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 1982;53(2):205-216

Virus-induced demyelination in herpes simplex virus-infected mice.

Kristensson K; Svennerholm B; Vahlne A; Nilheden E; Persson L; Lycke E
Journal article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 1979;43(2):253-263

Latent herpes simplex virus trigeminal ganglionic infection in mice and demyelination in the central nervous system.

Kristensson K; Svennerholm B; Persson L; Vahlne A; Lycke E
Journal article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 1978;35(2-3):331-340

Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation.

Kristensson K; Vahlne A; Persson LA; Lycke E
Visa fler

Alla övriga publikationer

Review: ISCIENCE. 2023;26(6):106935

Biological mechanisms underpinning the development of long COVID.

Perumal R; Shunmugam L; Naidoo K; Wilkins D; Garzino-Demo A; Brechot C; Vahlne A; Nikolich J
Review: VACCINE. 2023;41(20):3171-3177

Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies.

Roper RL; Garzino-Demo A; Del Rio C; Bréchot C; Gallo R; Hall W; Esparza J; Reitz M; Schinazi RF; Parrington M; Tartaglia J; Koopmans M; Osorio J; Nitsche A; Huan TB; LeDuc J; Gessain A; Weaver S; Mahalingam S; Abimiku A; Vahlne A; Segales J; Wang L; Isaacs SN; Osterhaus A; Scheuermann RH; McFadden G
Review: FRONTIERS IN IMMUNOLOGY. 2023;14:1117464

Long COVID: a review and proposed visualization of the complexity of long COVID.

Perumal R; Shunmugam L; Naidoo K; Abdool Karim SS; Wilkins D; Garzino-Demo A; Brechot C; Parthasarathy S; Vahlne A; Nikolich JŽ
Letter: LANCET. 2020;396(10248):e15

COVID-19-a very visible pandemic.

King C; Einhorn L; Brusselaers N; Carlsson M; Einhorn S; Elgh F; Frisén J; Gustafsson Å; Hanson S; Hanson C; Hedner T; Isaksson O; Jansson A; Lundkvist Å; Lötvall J; Lundback B; Olsen B; Söderberg-Nauclér C; Wahlin A; Steineck G; Vahlne A
Review: ANTIVIRAL RESEARCH. 2019;172:104645

2019 meeting of the global virus network.

Akkina R; Garry R; Bréchot C; Ellerbrok H; Hasegawa H; Menéndez-Arias L; Mercer N; Neyts J; Romanowski V; Segalés J; Vahlne A
Editorial comment: ACTA PAEDIATRICA. 2016;105(7):728-729

How Zika virus made the transition from being a virtually unknown virus to a high-profile public health threat.

Vahlne A
Letter: AIDS. 2013;27(10):1680-1682

Human serum increases CD4 recycling to plasma membranes of in-vitro cultured cells.

Perdomo MF; Vahlne A
Meeting abstract: RETROVIROLOGY. 2005;2:s94

AlphaHGA;: A new antiviral substance against HIV affecting capsid assembly

Vahlne A; Abdurahman S; Levi M; Andersson E; Svennerholm B; Horal P; Jejcic A; Hoglund S; Vegvaris A; Hogberg M; Balzarini J
Meeting abstract: RETROVIROLOGY. 2005;2:p80

Redirecting the specificity of naturally occurring antibodies using gal-alpha1, 3-gal coupled to HIV recognizing peptides

Perdomo M; Levi M; Sallberg M; Vahlne A
Letter: AIDS. 2000;14(1):91-92

Coreceptor usage of HIV-1 after deletion of Gly317-Pro318-Gly319 motif in the gp120 V3 loop.

Su J; Vahlne A
Conference publication: AIDS. 2000;14:S17-S18

An initial safety and efficacy clinical trial of GPG-NH₂, a tripeptide with a new antiretroviral made of action

Pehrson PO; Sönnerborg A; Vahlne A; Spira J
Other: JOURNAL OF INFECTIOUS DISEASES. 1995;172(5):1343-1347

Emergence of precore TAG mutation during hepatitis B e seroconversion and its dependence on pregenomic base pairing between nucleotides 1858 of 1896.

Lindh M; Furuta Y; Vahlne A; Norkrans G; Horal P
Conference publication: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 1985;9(3):310-311

HERPES-SIMPLEX VIRUS-INFECTION OF NEURONAL CELLS-INVITRO

LYCKE E; KRISTENSSON K; SVENNERHOLM B; VAHLNE A; ZIEGLER R

Anställningar

Professor Emeritus/Emerita, Laboratoriemedicin, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, klinisk virologi, Göteborgs Universitet, 1980

Om mig

Forskningsbeskrivning

Undervisning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI